Navigation Links
Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
Date:2/6/2008

CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming BIO CEO & Investor Conference on Tuesday, February 12, 2008 at 9:30 a.m. ET in the Park Avenue Suite Center/North Room at the Waldorf-Astoria Hotel in New York, NY.

The live and archived webcasts of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com or directly linking to http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=131556&eventID=1752370. (Due to the length of URL, please cut and paste into browser). Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fir...I ) today announced revenue guidance for the fourt... $57 million, as compared with $69 million for the...r 2008 results was the first of two installment pa...ed in fourth quarter 2008 results was a one-time $...
(Date:12/1/2009)... , PLYMOUTH, Mass., Dec. 1 Harv...ounced today results from the company sponsored 60...ra Medical Center in Chennai, India using the comp...structable Critical Limb Ischemia (CLI). Sri Ramac...tional-associated institution based in Chennai, In...
(Date:12/1/2009)... , SARASOTA, Fla., Dec. 1 Exp...Osprey Biotechnics Inc. of Sarasota has appointed ...butor. ,, Lake is located near Birmingham, Eng... bacteria which serve the agricultural, waste wate...d to be hungry and to open drain fields, and clean...
(Date:12/1/2009)... EpiVax, Inc. today announced a... RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax...ould potentially reduce detrimental immune respons...iVax collaboration, the EpiVax Tregitope technolog...enicity of protein therapeutics. , ...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
... Sept. 3 Wyeth (NYSE: WYE ),today announced the ...sident, Corporate Communications. Reporting to Tim...airs, Mr. McIntyre will be responsible for all,int...ion and its three,major divisions -- pharmaceutica...nd the world., Prior to joining Wyeth, Mr. McInty...
...n., Sept. 3 Mathematicians and,biologists from ar...Tennessee, Knoxville, to take part in a new instit...ssing problems from animal disease to wildfire,con...awarded UT Knoxville $16,million to begin the Nati...thesis, or NIMBioS. UT Knoxville won the award in ...
..., Sept. 3 Inverness Medical,Innovations, Inc. (Am... rapid,diagnostic products for the consumer and pr...iger, Chairman, Chief Executive Officer and,Presid... scheduled to,present at the Morgan Stanley Global...mber 9th, 2008 in New York. Their presentation is ...
Other Biology Technology:Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications 2UT Knoxville Wins $16M Mathematics and Biology Center 2UT Knoxville Wins $16M Mathematics and Biology Center 3
(Date:12/2/2009)...ground beef, peanut butter, and other foods have d...bout food safety. They also are quietly fueling a ...fostering new food safety regulations. That,s the ...ssue of Chemical & Engineering News , (C&EN) ACS,...llian Kemsley and Senior Correspondent Marc Reisch...
(Date:12/2/2009)...t that wearing a cap is good for you, at least if ...hns Hopkins Engineering in Oncology Center have sh...ad-like fibers holds the cell,s nucleus, its genet...this cap,s influence on cell and nuclear shape, th...nosis and treatment of diseases such as cancer, mu...
(Date:12/2/2009)... , REDWOOD SHORES, Calif. and PALM HARBOR, Fla....ntelligence Corporation ("CIC") (OTC Bulletin Boar...re solutions for business process automation in th...in biometric signature verification and Docubase S...Electronic Document Management (EDM) software prov...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Orthocare Innovations Receives Prestigious R 26D 100 Award for Computerized Prosthesis Alignment System 52210 1Orthocare Innovations Receives Prestigious R 26D 100 Award for Computerized Prosthesis Alignment System 52210 2Orthocare Innovations Receives Prestigious R 26D 100 Award for Computerized Prosthesis Alignment System 52210 3The Secrets to Staying Beautiful 3B Making the Most of Your Beauty Budget 52206 1The Secrets to Staying Beautiful 3B Making the Most of Your Beauty Budget 52206 2The Secrets to Staying Beautiful 3B Making the Most of Your Beauty Budget 52206 3BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52202 1BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52202 2BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52202 3
...es of climate evolution and the ecology of past-ti...ariables needed to complete the picture have been ...ed a formula which will fill in the gaps of our kn...el method of reconstructing missing data will shed...from ice ages to warmer periods as researchers wil...
...GTON, May 8 Military and civilian personnel from ...nd local homeland security, law enforcement and ot...United States, and defense media have been encoura...on Equipment Demonstration (FPED VII). The event w...e Corps Base, Quantico, VA, during May 19-21. , ,...
...ma Law Enforcement Data Sharing Consortium Now I... BIO-key International, Inc. (OTC Bulletin Board: ...cation and wireless public safety solutions, today... Oklahoma Sheriff,s Office for MobileCop(R), BIO-k...obileCop on laptops in their vehicles, the departm...
Other Biology News:Scientists find formula to uncover our planet's past and help predict its future 2Demonstration Features Commercial Technology for Combating Terrorism 2Tulsa County Sheriff Selects BIO-key(R) Mobile Data System 2
Mouse Anti-Calcium Channel alpha 2 delta-2 Monoclonal Antibody, Unconjugated, Clone 42 from BD Biosciences Pharmingen
Mouse Anti-Neuropilin-2 Monoclonal Antibody, Unconjugated, Clone 54 from BD Biosciences Pharmingen
Dynabeads M-450 Epoxy from Dynal Biotech
Mouse Anti-CBF-B Monoclonal Antibody, Unconjugated, Clone G-2 from Santa Cruz Biotechnology, Inc.
Biology Products: